{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:06:44Z","timestamp":1778213204648,"version":"3.51.4"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T00:00:00Z","timestamp":1606694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Pathophysiology of systemic sclerosis (SSc, Scleroderma), an autoimmune rheumatic disease, comprises of mechanisms that drive vasculopathy, inflammation and fibrosis. Understanding of the disease and associated clinical heterogeneity has advanced considerably in the past decade, highlighting the necessity of more specific targeted therapy. While many of the recent trials in SSc failed to meet the primary end points that predominantly relied on changes in modified Rodnan skin scores (MRSS), sub-group analysis, especially those focused on the basal skin transcriptomic data have provided insights into patient subsets that respond to therapies. These findings suggest that deeper understanding of the molecular changes in pathways is very important to define disease drivers in various patient subgroups. In view of these challenges, we performed meta-analysis on 9 public available SSc microarray studies using a novel pathway pivoted approach combining consensus clustering and machine learning assisted feature selection. Selected pathway modules were further explored through cluster specific topological network analysis in search of novel therapeutic concepts. In addition, we went beyond previously described SSc class divisions of 3 clusters (e.g. inflammation, fibro-proliferative, normal-like) and expanded into a much finer stratification in order to profile SSc patients more accurately. Our analysis unveiled an important 80 pathway signatures that differentiated SSc patients into 8 unique subtypes. The 5 pathway modules derived from such signature successfully defined the 8 SSc subsets and were validated by <jats:italic>in-silico<\/jats:italic> cellular deconvolution analysis. Myeloid cells and fibroblasts involvement in different clusters were confirmed and linked to corresponding pathway activities. Collectively, our findings revealed more complex disease subtypes in SSc; Key gene mediators such as IL6, FGFR1, TLR7, PLCG2, IRK2 identified by network analysis underscored the scientific rationale for exploring additional targets in treatment of SSc.<\/jats:p>","DOI":"10.1371\/journal.pone.0242863","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T13:51:20Z","timestamp":1606744280000},"page":"e0242863","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Transcriptional insights into pathogenesis of cutaneous systemic sclerosis using pathway driven meta-analysis assisted by machine learning methods"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7254-7951","authenticated-orcid":true,"given":"Xiao","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8737-5790","authenticated-orcid":true,"given":"Meera","family":"Ramanujam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha","family":"Visvanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shervin","family":"Assassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1023-9157","authenticated-orcid":true,"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,11,30]]},"reference":[{"key":"pone.0242863.ref001","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CLEP.S191418","article-title":"Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease","volume":"11","author":"A Bergamasco","year":"2019","journal-title":"Clin Epidemiol"},{"issue":"4","key":"pone.0242863.ref002","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2174\/157339710793205657","article-title":"T-cells and B-cells in systemic sclerosis","volume":"6","author":"IS L","year":"2010","journal-title":"Curr Rheumatol Rev"},{"issue":"5","key":"pone.0242863.ref003","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1042\/CS20130367","article-title":"Innate immunity in systemic sclerosis pathogenesis","volume":"126","author":"S. O'Reilly","year":"2014","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"pone.0242863.ref004","first-page":"1212","article-title":"Classification of systemic sclerosis. Visions and reality","volume":"44","author":"FA Wollheim","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"pone.0242863.ref005","doi-asserted-by":"crossref","first-page":"835948","DOI":"10.1155\/2013\/835948","article-title":"Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis","volume":"2013","author":"SA Jimenez","year":"2013","journal-title":"ISRN Rheumatol"},{"issue":"11","key":"pone.0242863.ref006","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"F van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"pone.0242863.ref007","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaut.2013.01.012","article-title":"Systemic sclerosis: genetics and epigenetics","volume":"41","author":"Y Luo","year":"2013","journal-title":"J Autoimmun"},{"issue":"3","key":"pone.0242863.ref008","first-page":"210","article-title":"HLA typing in systemic sclerosis","volume":"53","author":"E Favalli","year":"2001","journal-title":"Reumatismo"},{"issue":"2","key":"pone.0242863.ref009","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/BOR.0b013e3283367c17","article-title":"The genetics of scleroderma (systemic sclerosis)","volume":"22","author":"SK Agarwal","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"pone.0242863.ref010","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1017\/erm.2013.10","article-title":"Role of toll-like receptors in systemic sclerosis","volume":"15","author":"M Ciechomska","year":"2013","journal-title":"Expert Rev Mol Med"},{"key":"pone.0242863.ref011","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1874312901408010029","article-title":"Systemic Sclerosis is a Complex Disease Associated Mainly with Immune Regulatory and Inflammatory Genes","volume":"8","author":"J Jin","year":"2014","journal-title":"Open Rheumatol J"},{"issue":"8","key":"pone.0242863.ref012","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3109\/08916934.2012.719946","article-title":"Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis","volume":"45","author":"N Maugeri","year":"2012","journal-title":"Autoimmunity"},{"issue":"9","key":"pone.0242863.ref013","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1002\/art.21246","article-title":"Involvement of alphavbeta5 integrin-mediated activation of latent transforming growth factor beta1 in autocrine transforming growth factor beta signaling in systemic sclerosis fibroblasts","volume":"52","author":"Y Asano","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"4","key":"pone.0242863.ref014","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"KG MacDonald","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"3\u20134","key":"pone.0242863.ref015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00011-015-0806-0","article-title":"Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis","volume":"64","author":"XL Huang","year":"2015","journal-title":"Inflamm Res"},{"issue":"5","key":"pone.0242863.ref016","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00281-015-0511-7","article-title":"Cytokines in the immunopathology of systemic sclerosis","volume":"37","author":"J Raja","year":"2015","journal-title":"Semin Immunopathol"},{"issue":"1","key":"pone.0242863.ref017","doi-asserted-by":"crossref","first-page":"e1004005","DOI":"10.1371\/journal.pcbi.1004005","article-title":"Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms","volume":"11","author":"JM Mahoney","year":"2015","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"pone.0242863.ref018","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/annrheumdis-2018-214778","article-title":"Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis","volume":"78","author":"SJ Moon","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"pone.0242863.ref019","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13075-015-0669-3","article-title":"Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis","volume":"17","author":"EF Chakravarty","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"pone.0242863.ref020","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1002\/art.39289","article-title":"Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis","volume":"67","author":"S Assassi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"pone.0242863.ref021","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/jid.2011.472","article-title":"Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies","volume":"132","author":"SA Pendergrass","year":"2012","journal-title":"J Invest Dermatol"},{"key":"pone.0242863.ref022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"S Hanzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"pone.0242863.ref023","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-60761-175-2_5","article-title":"Manual annotation of protein interactions","volume":"563","author":"S Bureeva","year":"2009","journal-title":"Methods Mol Biol"},{"key":"pone.0242863.ref024","unstructured":"MetaBase (V 4.2.3) [Internet]. Thomson Reuters. 2019."},{"issue":"9","key":"pone.0242863.ref025","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1002\/art.34500","article-title":"JAK\u20102 as a novel mediator of the profibrotic effects of transforming growth factor \u03b2 in systemic sclerosis","volume":"64","author":"C Dees","year":"2012","journal-title":"Arthritis & Rheumatology"},{"key":"pone.0242863.ref026","doi-asserted-by":"crossref","first-page":"4569826","DOI":"10.1155\/2019\/4569826","article-title":"Systemic Sclerosis Pathogenesis and Emerging Therapies, beyond the Fibroblast","volume":"2019","author":"A Sierra-Sepulveda","year":"2019","journal-title":"Biomed Res Int"},{"issue":"8","key":"pone.0242863.ref027","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1002\/art.34424","article-title":"Wnt\/beta-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells","volume":"64","author":"J Wei","year":"2012","journal-title":"Arthritis Rheum"},{"key":"pone.0242863.ref028","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0377-0427(87)90125-7","article-title":"A graphical aid to the interpretation and validation of cluster analysis","volume":"20","author":"PJ Rousseeuw","year":"1987","journal-title":"J Comput Appl Math"},{"issue":"5","key":"pone.0242863.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building Predictive Models in R Using the caret Package","volume":"28","author":"M. Kuhn","year":"2008","journal-title":"Journal of Statistical Software"},{"key":"pone.0242863.ref030","first-page":"1","article-title":"A. ranger: A fast implementation of random forests for high dimensional data in C++ and R","volume":"77","author":"MNZ Wright","year":"2017","journal-title":"J Stat Softw"},{"key":"pone.0242863.ref031","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/1471-2105-11-460","article-title":"Candidate gene prioritization by network analysis of differential expression using machine learning approaches","volume":"11","author":"D Nitsch","year":"2010","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"pone.0242863.ref032","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ajhg.2008.02.013","article-title":"Walking the interactome for prioritization of candidate disease genes","volume":"82","author":"S Kohler","year":"2008","journal-title":"Am J Hum Genet"},{"key":"pone.0242863.ref033","unstructured":"Analytics C. CBDD. 15.1.0 ed2019."},{"issue":"1","key":"pone.0242863.ref034","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"WE Johnson","year":"2007","journal-title":"Biostatistics"},{"issue":"6282","key":"pone.0242863.ref035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"I Tirosh","year":"2016","journal-title":"Science"},{"issue":"12","key":"pone.0242863.ref036","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"MD Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"issue":"7","key":"pone.0242863.ref037","doi-asserted-by":"crossref","first-page":"e2696","DOI":"10.1371\/journal.pone.0002696","article-title":"Molecular subsets in the gene expression signatures of scleroderma skin","volume":"3","author":"A Milano","year":"2008","journal-title":"PLoS One"},{"issue":"1","key":"pone.0242863.ref038","doi-asserted-by":"crossref","first-page":"e0114017","DOI":"10.1371\/journal.pone.0114017","article-title":"Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts","volume":"10","author":"ME Johnson","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"pone.0242863.ref039","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar4430","article-title":"Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction","volume":"16","author":"X Yang","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"28","key":"pone.0242863.ref040","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar7754","article-title":"Type 3 cytokines IL-17A and IL-22 drive TGF-beta-dependent liver fibrosis","volume":"3","author":"T Fabre","year":"2018","journal-title":"Sci Immunol"},{"issue":"5","key":"pone.0242863.ref041","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41584-019-0212-z","article-title":"Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis","volume":"15","author":"G Kania","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"pone.0242863.ref042","doi-asserted-by":"crossref","first-page":"e000183","DOI":"10.1136\/bmjresp-2017-000183","article-title":"Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic study","volume":"4","author":"YD Zhao","year":"2017","journal-title":"BMJ Open Respir Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0242863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T13:52:00Z","timestamp":1606744320000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0242863"}},"subtitle":[],"editor":[{"given":"Jingwen","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,30]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0242863","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,30]]}}}